(Q39268634)

10 September 2017

title

Relationship of Mitten Patterns to Neuroleptic Drug Induced Dyskinesias in Psychiatric Patients: Early Investigative Findings (English)

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

2 November 2022

1 reference

F. A. Struve

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:38924

2 November 2022

J. M. Kane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:38924

2 November 2022

J. T. Wegner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:38924

2 November 2022

J. Kantor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:38924

2 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=38924

2 November 2022

publication date

1 July 1979

1 reference

full work available at URL

10 September 2017

http://journals.sagepub.com/doi/pdf/10.1177/155008637901000304

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

http://journals.sagepub.com/doi/full-xml/10.1177/155008637901000304

2 November 2022

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Clinical EEG (electroencephalography)

2 November 2022

published in

1 reference

10 September 2017

volume

10

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

151-163

1 reference

Extrapyramidal disorders after prolonged phenothiazine therapy

10 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine

2 November 2022

2

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate

2 November 2022

3

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Western Journal of Medicine

2 November 2022

4

125

277

Kabayashi R.M.

1976

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

2 November 2022

Tardive dyskinesia

5

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

2 November 2022

Persistent Dyskinesia

6

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Atypical tardive dyskinesia

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Tardive dyskinesia: are first signs reversible?

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

2 November 2022

Q64895699

13

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

The pharmacology of tardive dyskinesias

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

The dopamine hypothesis of schizophrenia: a review

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Drug Therapy of Tardive Dyskinesia

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Relationship between tardive dyskinesia, l-Dopa-induced hyperkinesia and parkinsonism

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Receptor sensitivity modification (RSM) — A new paradigm for the potential treatment of some hormonal and transmitter disturbances

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Effects of dopamine agonists in tardive dyskinesia

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Cholinergic influences in tardive dyskinesia

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Paradoxical response to dopamine agonists in tardive dyskinesia

2 November 2022

22

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

2 November 2022

24

100

751

Sigwald J.

1959

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Neurological syndromes associated with antipsychotic drug use. A special report.

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

A survey of tardive dyskinesia in psychiatric outpatients

2 November 2022

29

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis

2 November 2022

31

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

The B-mitten EEG pattern and tardive dyskinesia: a possible association

2 November 2022

32

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

The relative incidence of the B-mitten EEG pattern in process and reactive schizophrenia

2 November 2022

37

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

B-Mitten EEG pattern and process and reactive schizophrenia. A replication

2 November 2022

40

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Psychopharmacology communications

2 November 2022

48

2

125

Davis K.L.

1976

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

Parkinson's disease, depression, and ECT: a review and case study

2 November 2022

50

1 reference

https://api.crossref.org/works/10.1177/155008637901000304

2 November 2022

Identifiers

0 references

1 reference